- $4.82bn
- $4.88bn
- $314.71m
- 64
- 13
- 90
- 56
Annual income statement for Glaukos, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 237 | 225 | 294 | 283 | 315 |
| Cost of Revenue | |||||
| Gross Profit | 198 | 133 | 227 | 214 | 239 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 287 | 349 | 327 | 365 | 443 |
| Operating Profit | -50.3 | -124 | -32.9 | -82.3 | -129 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -50 | -132 | -49.3 | -98.4 | -134 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 15.4 | -120 | -49.6 | -99.2 | -135 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 15.4 | -120 | -49.6 | -99.2 | -135 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 15.4 | -120 | -49.6 | -99.2 | -135 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.466 | -2.63 | -1.25 | -2.29 | -2.68 |